Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/obese Women with PCOS
A prospective study to determine the metabolic effects of the contraceptive vaginal ring among overweight and obese women with polycystic ovary syndrome (PCOS). We will recruit a total of 40 participants and study use of the vaginal ring over a 4-month period.
Polycystic Ovary Syndrome
DRUG: Etonogestrel/ethinyl estradiol vaginal ring
Incidence of Metabolic Syndrome, Metabolic Syndrome defined according to the updated Adult Treatment Panel III as 3 or more of the following criteria: blood pressure ≥130/85 mm Hg, waist circumference \>35 inches, fasting glucose ≥110 mg/dL, TG ≥150 mg/dL, HDL-C \<50 mg/dL., 4 months
Change in low-density lipoprotein (LDL) measure, 4 months|Change in high-density lipoprotein (HDL) measure, 4 months|Change in triglycerides measure, 4 months|Change in apolipoprotein A, 4 months|Change in apolipoprotein B, 4 months|Change in advanced lipid testing measure, 4 months|Change in cholesterol efflux capacity, 4 months|Change in fasting insulin level, 4 months|Change in fasting 2 hour oral Glucose Tolerance Test result, 4 months|Change in Testosterone, 4 months|Change in Ferriman-Gallwey Hirsutism score, A lower score indicates less hirsutism. The F-G scoring system has a minimum value of 0, and a maximum value of 36., 4 months|Body Mass Index, 4 months|Change in scoring on the Center for Epidemiologic Studies Depression Scale, The range of values is zero to 60, with the higher scores indicating the presence of more depressive symptoms., 4 months|Change in scoring on the State-Trait Anxiety Inventory, The State-Trait Anxiety Inventory measures both state and trait anxiety, the scores range from 20 to 80, with higher scores correlating with greater anxiety., 4 months|Change in scoring on Polycystic Ovary Syndrome Quality of Life Questionnaire, Worse quality of life is associated with a lower score on the questionnaire, with a range score from 30 to 210., 4 months
A prospective study to determine the metabolic effects of the contraceptive vaginal ring among overweight and obese women with polycystic ovary syndrome (PCOS). We will recruit a total of 40 participants and study use of the vaginal ring over a 4-month period.